Меню
Идёт набор NCT05582551

Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors

Без фазы С лечением Childhood Cancer

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Highlighting Patients at Risk for Sensory Screening (HPARSS).
Кому может быть актуально
Состояния в реестре: Childhood Cancer. Базовые параметры: 7 лет — 17 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
США
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Не всё понятно в терминах? Прочитайте наш гид для пациентов →

Официальное название

Highlighting Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors

Обзор

The overall goal of this study is to attempt to overcome the organizational barriers that impede prompt screening for at-risk sensory deficits in childhood cancer survivors (CCS). Using a cross sectional design study, collaborators in the Informatics Research branch of the Institute of Informatics at the Washington University School of Medicine will identify CCS at risk for sensory deficits based upon their therapy exposure to generate the highlighting patients at risk for sensory screening (HPARSS) document. The investigators will utilize the HPARSS that will link therapy related risks for sensory deficits to specific screening procedures prompting the primary oncology provider to implement screening, diagnostic testing, and therapy.

Вмешательства

  • Другое Highlighting Patients at Risk for Sensory Screening (HPARSS)
    Collaborators in the Informatics Research branch of the Institute of Informatics at the Washington University School of Medicine will identify CCS at risk for sensory deficits based upon their therapy exposure to generate the HPARSS document.

Первичные конечные точки

  • Percentage of patients with at risk for sensory deficits identified by HPARSS [Срок оценки: Through completion of enrollment for all patients (estimated to be 9 months)]
  • Percentage of at risk patients who fail the assigned screening test [Срок оценки: Through completion of enrollment for all patients (estimated to be 9 months)]
  • Percentage of patients in need of referral for screen test results who participate in formal diagnostic testing and/or treatment [Срок оценки: Through 1 year after the completion of screening test for all participants (estimated to be 1 year and 9 months)]
Вторичные конечные точки (4)
  • Number and types of barriers to participation in formal diagnostic testing and therapy in CCS failing to engage in sensory screening [Срок оценки: At approximately 2 months following the patient's screening]
  • Number and types of facilitators to participation in formal diagnostic testing and therapy in CCS failing to engage in sensory screening [Срок оценки: At approximately 2 months following the patient's screening]
  • Acceptability of HPARSS as measured by the Acceptability of Intervention Measure (AIM) [Срок оценки: To be completed at the time of enrollment completion (approximately 9 months)]
  • Feasibility of intervention as measured by Feasibility of Intervention Measure (FIM) [Срок оценки: To be completed at the time of enrollment completion (approximately 9 months)]

Критерии участия

Критерии включения

  • Patients with a diagnosis of pediatric cancer (diagnosis at <18 years of age)
  • Treatment including chemotherapy and/or radiation therapy
  • Completion of all cancer therapy for at least 6 months and less than 2 years
  • Followed in the Division of Pediatric Hematology/Oncology Program at the Washington University School of Medicine
  • Current age between 7 and 17 years of age (age where all of the screening tests are both valid and have been successfully performed by our group)
  • English speaking

Критерии исключения

  • Undergoing active cancer treatment
  • Patient under the care of the Late Effects Program at St. Louis Children's Hospital
  • Received previous diagnostic testing or rehabilitative therapy for a secondary deficit eligible for screening.
  • Parents and/or patient illiteracy
  • No contact with treatment team in the past two years
  • In foster care or without a legal guardian

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Нерандомизированное
Модель
Параллельные группы
Маскирование
Открытое
Основная цель
Организация здравоохранения

Центры проведения

США · 1 центр
  • St. Louis Children's Hospital - Washington University School of Medicine — St Louis

Идентификаторы

NCT: NCT05582551 · 202208066

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗